These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3865632)

  • 1. Cefotiam therapy of lower respiratory tract infections.
    Polis MA; Tuazon CU
    Antimicrob Agents Chemother; 1985 Oct; 28(4):576-7. PubMed ID: 3865632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative clinical study of ceftazidime and cefotiam for respiratory tract infections by a double-blind method].
    Hara K; Saito A; Yamaguchi K; Suzuyama Y; Shigeno Y; Nakamura I; Oda T; Okuno K; Iwasaki H; Saito A
    Kansenshogaku Zasshi; 1984 Jul; 58(7):663-702. PubMed ID: 6096454
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
    Beumer HM; Olislagers WP; Kahn M; van Hamersveld JD
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on cefotiam in pediatric infections (author's transl)].
    Okamoto K; Shino K; Fuke H; Watanabe K; Ozaki H
    Jpn J Antibiot; 1981 Jun; 34(6):1019-26. PubMed ID: 6270418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of cefotiam in the treatment of bacterial infections].
    Mussini C; Zanni G; Braglia MP
    Clin Ter; 1984 Dec; 111(5):401-9. PubMed ID: 6097395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum levels and sputum levels of cefmenoxime in respiratory tract infections].
    Matsumoto Y; Ninomaru S; Koshobu T; Ishikawa J; Nakatani S; Sasaki T
    Jpn J Antibiot; 1985 Jun; 38(6):1638-42. PubMed ID: 3862881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of cefotiam in internal medicine].
    Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Aizawa M; Nara H; Yanagiya S; Fukushi K; Ohmi T; Okamoto K; Komatsu Y; Haneda Y; Tanabe K; Segawa M; Yamagata A; Kawatsu S
    Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
    Guibert J; Coppens H; Yvelin C
    Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update on antibiotic therapy. 7) Cefotiam].
    Di Nola F
    Minerva Med; 1982 Jul; 73(30-31):2057-60. PubMed ID: 6285229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of effectiveness of cefodizime in the treatment of lower respiratory tract infections with parenchymal involvement.
    Pauwels RA
    Infection; 1992; 20 Suppl 1():S26-30. PubMed ID: 1526672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriological and clinical studies of cefodizime in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
    Lentnek A; Wikler M; McDevitt J; Sohn C
    Clin Ther; 1984; 7(1):33-9. PubMed ID: 6097357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory and clinical studies of cefmenoxime in pediatric infections].
    Miyachi Y; Nakashima T; Aso K; Nishikawa K; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1982 Oct; 35(10):2459-67. PubMed ID: 6306297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial potency of cefotiam based on the clinical effect, MIC and decrement of organisms in the sputum].
    Kawagoe M; Narushima K; Kitani A; Shibuya T; Hara M; Hosono K; Shitara M
    Jpn J Antibiot; 1983 Aug; 36(8):2053-7. PubMed ID: 6317912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pharmacokinetic evaluation of cefodizime in children].
    Hirabayashi Y; Higashino H; Kino M; Nobori U; Okazaki H; Kitamura N; Kobayashi Y
    Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.